Neotract, Inc.
Clinical trials sponsored by Neotract, Inc., explained in plain language.
-
Head-to-Head: which BPH treatment gets men off catheters faster?
Disease control OngoingThis study compares two minimally invasive treatments for enlarged prostate (BPH): the UroLift System and the Rezūm System. Researchers are tracking 120 men for 12 months to see which treatment helps patients avoid catheters more quickly and reduces the need for additional BPH me…
Phase: NA • Sponsor: NeoTract, Inc. • Aim: Disease control
Last updated Apr 02, 2026 07:41 UTC
-
Prostate treatment study cancelled before launch
Disease control TerminatedThis study aimed to compare how well different treatments work for men with bothersome urinary symptoms from an enlarged prostate. It planned to look at real-world patients' experiences with various treatment options over several months. The study was withdrawn before any partici…
Sponsor: NeoTract, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC